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Do	topical	antibiotics		
improve	wound	healing?
e v i d e n c e - b a s e d  a n s w e r
The use of topical triple-antibiotic oint-
ments significantly decreases infection 
rates in minor contaminated wounds 
compared with a petrolatum control. Plain 
petrolatum ointment is equivalent to triple-
antibiotic ointments for sterile wounds as a 
post-procedure wound dressing (strength 
of recommendation [sor]: a, based on 
randomized controlled trials [rCTs]). 
Mupirocin cream is as effective as oral 
cephalexin in the treatment of second-
arily infected minor wounds and, because 
of better tolerability, is the treatment of 
choice for the prevention and treatment 
of Staphylococcus aureus and Staphy-
lococcus pyogenes infections. emerging 
resistance, including methicillin-resistant 
S aureus (Mrsa), makes it prudent to 
check for clinical response in 24 to 48 
hours. Major contaminated wounds 
requiring parenteral antibiotics do not 
appear to additionally benefit from 
topical antibiotics (sor: a, based on 
rCTs).
Topical antibiotics may also aid in the 
healing of chronic wounds (sor: B, based 
on a systematic review of low-quality 
rCTs), as does the application of honey 
(sor: B, based on a systematic review of 
cohort studies). 
c l i n i c a l  c o m m e n t a r y
it would be helpful to have objective 
criteria to properly classify skin wounds
These results are encouraging, but they 
do not fully account for variability in the 
diagnosis of skin wounds or in the practi-
cal use of topical agents. The evaluation of 
skin wounds is inherently subjective. In or-
der to properly apply these findings to my 
practice, it would be helpful to have more 
objective diagnostic criteria to properly 
classify skin wounds. 
furthermore, how patients use topical 
agents varies considerably. Patients ap-
ply topical agents differently, due to indi-
vidual preference or perhaps inconsistent 
recommendations from their physician. 
used improperly, topical agents may not 
provide the same potential for clinical 
improvement.
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n	Evidence	summary
Topical	antibiotics		
for	prophylaxis
Numerous studies support the prophy-
lactic application of topical antibiotics to 
wounds that are clean. Topical bacitra-
cin zinc (Bacitracin), a triple ointment of 
neomycin sulfate, bacitracin zinc, and 
polymyxin B sulfate (Neosporin), and 
silver sulfadiazine (Silvadene) were com-
pared with petrolatum as a control in a 
well-conducted RCT of 426 patients with 
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uncomplicated wounds seen at a military 
community hospital. Wound infection 
rates were 17.6% (19/108) for petrola-
tum, 5.5% (6/109) for Bacitracin (num-
ber needed to treat [NNT]=8), 4.5% 
(5/110) for Neosporin (NNT=8), and 
12.1% (12/99) for Silvadene (NNT=18).1 
Most (60%) of the infections were “stitch 
abscesses” and were treated with local 
care only. There was no difference in 
rates of more serious infections between 
groups. One patient (0.9%) developed a 
hypersensitivity reaction to Neosporin.
A clinical trial compared the efficacy of 
a cetrimide, bacitracin zinc, and polymyxin 
B sulfate gel (a combination not available 
in the US) with placebo and povidone-
iodine cream in preventing infections in 
177 minor wounds (cuts, grazes, scrapes, 
and scratches) among children. The anti- 
biotic gel was found to be superior to 
placebo and equivalent to povidone- 
iodine, in that it reduced clinical infections 
from 12.5% to 1.6% (absolute risk reduc-
tion [ARR]=0.109; 95% confidence inter-
val [CI], 0.011–0.207; NNT=11).2 
A double-blind study of 59 patients 
found Neosporin superior to placebo 
ointment in the prevention of streptococ-
cal pyoderma for children with minor 
wounds. Infection occurred in 47% of 
placebo-treated children compared with 
15% treated with the triple-antibiotic 
ointment (NNT=32; P=.01).3 
A small randomized prospective 
trial of 99 patients, who self-reported 
compliance with wound care and dress-
ing changes, compared Neosporin with 
mupirocin (Bactroban) in preventing infec-
tions in uncomplicated soft tissue wounds. 
The study found no statistical difference 
in infection rates, and the authors recom-
mend the more cost-effective Neosporin, 
as well as a larger trial to confirm the 
results.4
Another randomized controlled tri-
al  of 933 outpatients—with a total of 
1249 wounds from sterile dermatologic 
surgeries—compared white petrolatum 
with bacitracin zinc ointment prophy-
laxis. The study found no statistically 
significant differences in post-procedure 
infection rates, though only 13 patients 
developed an infection (2% in petro- 
latum group vs. 0.9% in bacitracin 
zinc group; 95% CI for the difference, 
–0.4 to 2.7).5
Topical	antibiotics		
for	treatment
Topical antimicrobials are appealing for 
the treatment of secondarily infected 
wounds for the sake of convenience and 
because they may reduce the risk of ad-
verse effects. 
An open randomized trial with 
48 volunteers compared the effects of 
Neosporin with several antiseptics (3% 
hydrogen peroxide, 1% povidone-io-
dine, 0.25% acetic acid, 0.5% sodium 
hydrochloride) and a wound protectant 
(Johnson & Johnson First Aid Cream 
without antimicrobial agent) on blister 
wounds (6 blisters per volunteer) inten-
tionally contaminated with S aureus. Only 
Neosporin eliminated the infection after 
2 applications (at 16 and 24 hours). Both 
the antibiotic ointment and the wound 
protectant led to faster wound healing 
by about 4 days compared with the anti- 
septics or no treatment.6
Another study with 2 parallel, identi-
cal RCTs of a total of 706 patients found 
mupirocin cream (Bactroban) to be equiv-
alent to oral cephalexin in the treatment 
of secondarily infected minor wounds, 
such as small lacerations, abrasions, or 
sutured wounds. Clinical success (95.1% 
for mupirocin and 95.3% for cephalexin), 
bacteriologic success (96.9% for mupi-
rocin and 98.9% for cephalexin), as well 
as the intention-to-treat success rate of 
83% at follow-up were equivalent in the 
2 groups.7
A small but well-designed study of 62 
patients with major contaminated wounds 
failed to show any additional benefit 
when topical piperacillin/tazobactam (not 
available in US as a topical agent) was add-
ed to parenteral piperacillin/tazobactam 
(Zosyn) alone. Two of 31 patients on just 
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parenteral antibiotics and 3 of 31 patients 
on both topical and parenteral antibiotics 
developed wound infections (P>.05).8
Finally, topical antibiotics also appear 
to aid in the healing of chronic wounds. 
However, these findings are difficult to 
interpret in light of small sample size 
and other methodological problems. A 
systematic review of the treatment of 
chronic wounds, such as diabetic foot ul-
cers, found 30 trials, including 25 RCTs, 
mostly of low quality. Little evidence sup-
ports the routine use of systemic antibi-
otics for patients with chronic wounds; 
however, some topical antiseptic and an-
timicrobial agents may hasten the healing 
of these wounds. Topical preparations that 
may be helpful include dimethyl sulfoxide 
(Rimso-50), silver sulfadiazine (Silvad-
ene), benzoyl peroxide (Benzac, Brevoxyl, 
Desquam, Triaz, ZoDerm), oxyquinoline 
(Trimo-san Vaginal Jelly), and gentamicin 
(Garamycin).9 
Honey may also make an acceptable 
wound dressing for chronic wounds, as 
it has been repeatedly shown to suppress 
bacterial growth. Infection with Clos-
tridium spores does not appear to be a 
concern when treating chronic wounds 
with honey.10,11
Recommendations	from	others
Guidelines for antibiotic prophylaxis of 
surgical wounds uniformly recommend 
prophylaxis for all clean-contaminated, 
contaminated, and dirty procedures. Pro-
phylaxis is considered optional for most 
clean procedures, although it may be in-
dicated for certain at-risk patients and 
for clean procedures that fulfill specific 
risk criteria.12 
The Infectious Diseases Society of 
America recommends mupirocin as the 
best topical agent for the treatment and 
prevention of S aureus and S pyogenes 
infections, followed by bacitracin zinc 
and neomycin, although resistance is 
emerging.13 Expert and consensus opin-
ion from the Canadian Chronic Wound 
Advisory Board and the International 
Wound Bed Preparation Advisory Board 
for wound care management of infected 
chronic wounds recommend that since 
bacterial infection can develop gradually, 
good-quality wound cultures should be 
used in conjunction with clinical assess-
ment. Iodine and silver-based dressings, 
topical antibiotics, and systemic antibiot-
ics can be helpful.14 
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